Endo Begins Shipment of Authorized Generic Version of Colcrys® (colchicine, USP) in the United States

DUBLIN, July 2, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping an authorized generic version of Takeda Pharmaceutical's Colcrys® (colchicine, USP) 0.6 mg tablets. Endo's...

from PR Newswire: //https://ift.tt/2z4w9kQ